6,582 results on '"Morrow, David A."'
Search Results
202. Response to reviewer comments
203. Anticoagulation and Antiplatelet Therapy for Prevention of Venous and Arterial Thrombotic Events in Critically Ill Patients With COVID-19: COVID-PACT
204. Growth differentiation factor 15 and cardiovascular risk: individual patient meta-analysis
205. Position Statement on Vascular Access Safety for Percutaneous Devices in AMI Complicated by Cardiogenic Shock
206. Ethical aspects of the mitigation obstruction argument against climate engineering research
207. New Ischemic Stroke and Outcomes With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial
208. Coronary Stent Thrombosis With Vorapaxar Versus Placebo: Results From the TRA 2°P-TIMI 50 Trial
209. Editor's chronicles: redefining pathways in acute cardiac care.
210. Randomized, Placebo-Controlled Phase 2b Study to Evaluate the Safety and Efficacy of Recombinant Human Lecithin Cholesterol Acyltransferase in Acute ST-Segment–Elevation Myocardial Infarction: Results of REAL-TIMI 63B
211. Oxygenation targets in post-resuscitation care: a perspective of the BOX randomized clinical trial
212. Cytomegalovirus-vaccine-induced unconventional T cell priming and control of SIV replication is conserved between primate species
213. Blood pressure and oxygenation targets after out-of-hospital cardiac arrest-trial (BOX)
214. Critical Care Cardiology Trials Network (CCCTN): a cohort profile
215. A polygenic risk score predicts atrial fibrillation in cardiovascular disease
216. Epidemiology of heart failure hospitalization in patients with stable atherothrombotic disease: Insights from the TRA 2°P‐TIMI 50 trial
217. Hypergolic Continuous Detonation with Space-Storable Propellants and Additively Manufactured Injector Design
218. Relation of T-Wave Alternans to Mortality and Nonsustained Ventricular Tachycardia in Patients With Non–ST-Segment Elevation Acute Coronary Syndrome from the MERLIN-TIMI 36 Trial of Ranolazine Versus Placebo
219. High‐sensitivity C‐reactive protein, low‐density lipoprotein cholesterol and cardiovascular outcomes in patients with type 2 diabetes in the EXAMINE (Examination of Cardiovascular Outcomes with Alogliptin versus Standard of Care) trial
220. 2017 Cardiovascular and Stroke Endpoint Definitions for Clinical Trials
221. Frequency, Predictors, and Impact of Combined Antiplatelet Therapy on Venous Thromboembolism in Patients With Symptomatic Atherosclerosis
222. Salvation, Social Struggle, and the Ideology of the Company Merchant: Baptist Goodall’s The Tryall of Trauell (1630)
223. Alcohol Reduces Arterial Remodeling by Inhibiting Sonic Hedgehog‐Stimulated Stem Cell Antigen‐1 Positive Progenitor Stem Cell Expansion
224. Abstract 20183: Atherothrombotic Risk Stratification and Magnitude of Benefit of Evolocumab in FOURIER
225. Abstract 19116: Prognostic Performance of GDF-15 Across the Spectrum of Risk in Patients With NSTE-ACS Enrolled in MERLIN - TIMI 36
226. Abstract 19026: Prospective Registry of Cardiac Critical Illness in the Modern Cardiac Intensive Care Unit (CICU)
227. Abstract 18909: Progressive Myocardial Injury is Associated With Mortality in Patients With Non-cardiac Respiratory Failure
228. Abstract 17307: Biomarkers, Cardiovascular Outcomes and Effect of Ezetimibe After Acute Coronary Syndrome in the IMPROVE-IT Trial
229. Abstract 16714: Characterization of Types and Sizes of Myocardial Infarction Reduced With Evolocumab in FOURIER
230. Abstract 16613: Serial High-Sensitivity Troponin T and Cardiovascular Outcomes in Patients in the IMPROVE-IT Trial
231. Abstract 15480: The Efficacy and Safety of More Potent Antiplatelet Therapy With Vorapaxar in Patients With Impaired Renal Function: Insights From the TRA 2P-TIMI 50 Trial
232. Abstract 14230: A Methodology for Ascertaining Acute Limb Ischemia in Medicare Claims
233. Abstract 11709: Klotho, Fibroblast Growth Factor-23, and the Renin-Angiotensin System - An Analysis From the PEACE Trial
234. Prevalence and Prognostic Association of Circulating Troponin in the Acute Respiratory Distress Syndrome
235. Ensuring efficient development of personalized medicine by addressing regulatory needs: What role can research infrastructures play?
236. Deep vein thrombosis as thrombotic sequelae of vaccine-induced thrombotic thrombocytopenia.
237. Secretory Phospholipase A2-IIA and Cardiovascular Disease: A Mendelian Randomization Study
238. Dapagliflozin reduces uric acid concentration, an independent predictor of adverse outcomes in DAPA-HF
239. Myeloid cell tropism enables MHC-E–restricted CD8 + T cell priming and vaccine efficacy by the RhCMV/SIV vaccine
240. Supplementary material to "GCAM-CDR v1.0: Enhancing the Representation of Carbon Dioxide Removal Technologies and Policies in an Integrated Assessment Model"
241. GCAM-CDR v1.0: Enhancing the Representation of Carbon Dioxide Removal Technologies and Policies in an Integrated Assessment Model
242. Epidemiology and Management of ST‐Segment–Elevation Myocardial Infarction in Patients With COVID‐19: A Report From the American Heart Association COVID‐19 Cardiovascular Disease Registry
243. Malaria antigens are presented to CD8 T cells via the non-classical HLA-E
244. Harnessing the unique immune biology of cytomegalovirus for cancer immunotherapy
245. RhCMV/SIV tropism modulation programs unconventional CD8+ T cell priming and vaccine efficacy
246. Abstract 113: Novel Tissue Factor Inhibition For Thromboprophylaxis In COVID-19: Primary Results Of The ASPEN-COVID-19 Phase 2b Randomized Trial
247. Temporary Mechanical Circulatory Support Bridging Strategies And Post-operative Outcomes In Acute Decompensated Heart Failure-related Cardiogenic Shock Patients Undergoing Heart Transplantation Or Durable Left Ventricular Assist Device Implantation: A Society Of Thoracic Surgeons Database Analysis
248. Epidemiology of Acute Heart Failure in Critically Ill Patients With COVID-19: An Analysis From the Critical Care Cardiology Trials Network
249. Cardiac-Specific Troponins Beyond Ischemic Heart Disease
250. Airbus not expecting significant changes in production rates, says Faury
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.